Funding scale The organization has a substantial annual revenue in the high hundreds of millions range and a track record of multi-million annual investments in research and patient services, signaling strong funding capabilities and potential for large-scale partnerships or sponsored programs.

Collaborative partnerships Recent joint funding initiative with Myeloma Canada demonstrates openness to co-funding and cross-disease collaboration, suggesting opportunities for multi-organization partnerships, joint grant programs, and shared research initiatives.

Research emphasis With a large portion of funds dedicated to innovative research and acceleration of treatments, there is clear potential to propose sponsored research collaborations, clinical study support, and access to patient recruitment networks.

Patient support reach A significant commitment to patient services and education across Canada indicates opportunities to offer patient-facing tools, education platforms, and support program partnerships that align with their service delivery model.

Digital and outreach readiness Active online presence and a tech stack featuring Drupal, Microsoft 365, and digital engagement tools suggest compatibility for technology-enabled fundraising, grant management, and community engagement solutions.